IMRT in the treatment of locally advanced or inoperable NSCLC in the pre-durvalumab era: clinical outcomes and pattern of relapses, experience from the Oscar Lambret Center.

Le Roy, Thomas; Wallet, Jennifer; Barthoulot, Maël; Leguillette, Clémence; Lacornerie, Thomas; Pasquier, David; Lartigau, Eric; Le Tinier, Florence

Le Roy, Thomas; Wallet, Jennifer; Barthoulot, Maël; Leguillette, Clémence; Lacornerie, Thomas; Pasquier, David; Lartigau, Eric; Le Tinier, Florence.

Afiliação

Le Roy T; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France.
Wallet J; Department of Biostatistics, Centre Oscar Lambret, Lille, France.
Barthoulot M; Department of Biostatistics, Centre Oscar Lambret, Lille, France.
Leguillette C; Department of Biostatistics, Centre Oscar Lambret, Lille, France.
Lacornerie T; Department of Medical Physics, Centre Oscar Lambret, Lille, France.
Pasquier D; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France.
Lartigau E; CRIStAL UMR CNRS 9189, Lille University, Lille, France.
Le Tinier F; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France.

Front Oncol ; 13: 1236361, 2023.

Article em En | MEDLINE | ID: mdl-37810972

Palavras-chave

IMRT; NSCLC; isolated nodal failure; locally advanced or inoperable NSCLC; radiochemotherapy; radiotherapy; relapses

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google